Source: Annual Congress 2012 - Predicting and observing paediatric allergic disease
Disease area: Airway diseases, Paediatric lung diseases

Abstract

Background: Asthma is a chronic inflammatory diesease of the airways but recent studies have shown that alveoli are also subject of pathophysiological changes.
Objectives: This study was undertaken to compare leucotriene B4 (LTB₄) concentrations in different parts of the lungs using a new technique of fractionated breath condensate sampling.
Methods: In 69 patients (10-17 years, 34 asthmatics, 35 controls) measurements of exhaled nitric oxide (FE_NO), lung function and LTB₄ concentrations in exhaled breath condensate (EBC) were performed. EBC was collected in two different fractions, representing mainly either the airways or the alveoli, using captovolumetry. LTB₄ concentrations were measured using an ELISA.
Results: 44% and 49% of the LTB₄values were below the detection limit. Concentrations of the bronchial fraction correlated significantly with those of the alveolar fraction (r=0.73, p=0.000). Differences between the fractions were not significant in a paired difference test. Subjects with obstructive lung function (n=4) had significantly higher LTB₄ values than subjects with normal lung function (n= 65) (p=0.043, p=0.040, respectively). Asthmatics had significantely higher alveolar but not bronchial LTB₄ values than controls (p=0.005, p=0.232, respectively). There was no relationship between LTB₄ and FE_NO values.
Conclusions: Differences in LTB₄ concentrations between asthmatics and controls were only measurable in the alveolar but not in the bronchial fraction of EBC. An additional analysis of alveolar inflammation may therefore be possibly useful in asthmatics. However, lab techniques for analysing LTB₄ in EBC need to be improved and easy applicable.

Rating:

Share or cite this content

Citations should be made in the following way:
C.M. Mueller, J. Trischler, S. Könitzer, C. Lex (Halle (Saale), Germany). Leucotriene B4 in fractionated breath condensate: Comparison of bronchial and alveolar concentrations in children. Eur Respir J 2012; 40: Suppl. 56, 1937

Member's Comments

No comment yet.

Related content which might interest you: Saliva is one likely source of leukotriene B4 in exhaled breath condensate Source: Eur Respir J 2006; 28: 1229-1235 Year: 2006 The effect of smoking on the levels of cysteinyl leukotriene in exhaled breath condensate in asthmatics Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012 Increased exhaled breath condensate cysteinyl leukotriene concentration in exercise-induced bronchoconstriction Source: Annual Congress 2011 - Clinical application of exhaled biomarkers Year: 2011 Leukotriene B4 in exhaled breath condensate of patients after lung transplantation Source: Eur Respir J 2001; 18: Suppl. 33, 297s Year: 2001 Nasal lavage cysteinyl-leukotrienes correlate with exhaled breath condensate in children Source: Eur Respir J 2006; 28: Suppl. 50, 259s Year: 2006 Leukotriene B4 in exhaled breath condensate: impact of different breathing conditions during sampling Source: Eur Respir J 2001; 18: Suppl. 33, 165s Year: 2001 Cysteinyl leukotrienes and leukotriene B4 in expired breath condensate in patients with chronic asthma treated with montelukast Source: Eur Respir J 2003; 22: Suppl. 45, 101s Year: 2003 Thromboxane B2 and prostaglandin E2 concentrations in exhaled breath condensate in healthy volunteers and patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 509s Year: 2002 Cysteinyl leukotrienes in urine and exhaled breath condensate in asthmatics and COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 Exhaled bronchial NO and cysteinyl-leukotrienes in breath condensate in atopic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002 Validation of assays for inflammatory mediators in exhaled breath condensate Source: Eur Respir J 2008; 31: 943-948 Year: 2008 Correlation of LTB4 with α-amylase in exhaled breath condensate Source: Eur Respir J 2005; 26: Suppl. 49, 372s Year: 2005 Prostaglandin E2 in the expired breath condensate of patients with asthma Source: Eur Respir J 2003; 22: 743-747 Year: 2003 Levels of 8-isoprostane and LTB4 in exhaled breath condensate (EBC) in seasonal allergic rhinitis. Effect of therapy and allergen exposure Source: Eur Respir J 2004; 24: Suppl. 48, 678s Year: 2004 Cysteinyl leukotrienes in exhaled breath condensate are reduced after mite avoidance in allergic asthmatic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002 8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002 Measurements of prostaglandins E2 and D2 and their metabolites in exhaled breath condensate following bronchial provocation with aspirin in asthmatics Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy Year: 2013 Cysteinyl leukotrienes in exhaled breath condensate in children: noninvasive marker of remodeling? Source: Eur Respir J 2003; 22: Suppl. 45, 397s Year: 2003 Targeted eicosanoid lipidomics of induced sputum as compared to exhaled breath condensate in asthmatics Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002